CHICAGO (December 19, 2024) – The National Rosacea Society has introduced a new informational postcard about rosacea, a chronic facial skin disorder that affects more than 16 million Americans.

CHICAGO (September 23, 2024) — As a first step in a unique undertaking to boost rosacea research results by standardizing its study, a group of investigators including 63 experts from 17 countries as well as 25 rosacea patients have identified eight key aspects of the treatment or experience of rosacea, called core domains.

CHICAGO (June 18, 2024) — The National Rosacea Society (NRS) announced today the launch of the Rosacea Research Digest, a monthly email newsletter highlighting the latest research and news on rosacea. To subscribe, visit rosacea.org/researchdigest.

CHICAGO (April 15, 2024) — The National Rosacea Society (NRS) today announced several additions to the growing collection of skin care and cosmetic products that have earned its Seal of Acceptance, indicating they are suitable for use on sensitive rosacea skin.

The following products have been added to the directory of products at rosacea.org/seal-of-acceptance:

CHICAGO (April 1, 2024) – While rosacea sufferers can benefit from prescription medications and procedures to treat the full spectrum of potential signs and symptoms, a growing range of over-the-counter (OTC) skin care products is now available to help achieve optimal results.

CHICAGO (February 27, 2024) – While rosacea sufferers enjoy a wider range of therapeutic options than ever before, without proper skin care they may not get the most out of treatment, dermatologists warn. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on this chronic facial skin disorder estimated to affect more than 16 million Americans, and to urge those who suspect they may have it to see a dermatologist for diagnosis, treatment and guidance on gentle skin care.

CHICAGO (January 24, 2024) — For the first time, consumers shopping for skin care products and cosmetics that are suitable for people who suffer from rosacea — a chronic red-faced skin disorder affecting 1 in 20 Americans that is often characterized by flare-ups and remissions — will be able to look for a Seal of Acceptance from the National Rosacea Society (NRS). More information about the Seal and a catalog of products may be found on the NRS website at rosacea.org/seal-of-acceptance.

CHICAGO (November 7, 2023) — The National Rosacea Society (NRS) has awarded funding for one new study, in addition to continuing support for two ongoing studies, as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.

CHICAGO (June 21, 2023) — The National Rosacea Society (NRS) today announced that it is launching a Seal of Acceptance program to identify skin care and cosmetic products that may be suitable for people who suffer from rosacea. Companies interested in pursuing the Seal, to be displayed on accepted product packaging, may learn more and request an application online at www.rosacea.org/seal-of-acceptance/ or by contacting the Society at seal@rosacea.org.

CHICAGO (April 1, 2023) – Targeted rosacea therapies can lead to facial skin free of redness and blemishes, but only if these two key elements are also in place: the patient’s commitment to consistent adherence to the treatment plan and the patience to let it work. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on this conspicuous, life-disruptive facial disorder affecting 16 million Americans, and urge those who may have it to see a dermatologist for diagnosis and therapy tailored to their individual case.

CHICAGO (February 7, 2023) – Advanced therapies designed to target rosacea’s disease processes combined with treatment plans tailored to each individual’s specific case have made it easier than ever for patients to achieve clear skin. But these treatment advances are only beneficial if sufferers have the patience to allow therapies to do their job.

CHICAGO (November 29, 2022) — The National Rosacea Society (NRS) has awarded funding for two new studies in addition to continuing support for two ongoing studies as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.

CHICAGO (November 1, 2022) — The National Rosacea Society (NRS) celebrates its 30th anniversary in 2022. The past three decades have seen tremendous progress toward fulfilling our mission of improving the lives of people with rosacea through awareness, education and support of medical research.

“Thanks to the efforts of the NRS, its members and researchers studying on the disease, rosacea is both more recognized and better understood than ever before,” said Andrew Huff, executive director of the NRS.

CHICAGO (Sept. 14, 2022) — Researchers have long observed that microscopic mites that live as scavengers on normal human skin tend to occur in greater numbers on the faces of rosacea patients. It was unknown, however, whether the higher density of these microorganisms, known as Demodex, was a cause or an effect of this widespread disease affecting 16 million Americans.

BARRINGTON, Illinois (August 2, 2022) — The great majority of rosacea patients have experienced persistent facial redness, and most of them report it is the most frequently bothersome sign they face, according to a recent National Rosacea Society (NRS) survey on rosacea redness sponsored by EPI Health. Furthermore, two-thirds reported experiencing flare-ups more than once a week.

CHICAGO (April 1, 2022) — Thanks to the growing number of sophisticated rosacea therapies, the 16 million Americans with this potentially serious facial disorder who commit to partnering with their physicians can now expect to enjoy a clear complexion without the psychological and emotional burden of its unpredictable and embarrassing effects.

BARRINGTON, Illinois (February 8, 2022) — Sophisticated new therapies designed to target rosacea's disease processes combined with treatment plans tailored to patients’ specific cases have made it easier than ever for sufferers to achieve clear skin. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on the treatments available for this potentially serious disorder, as well as the importance of a key factor in making them effective: the patient’s ongoing commitment to comply with therapy.

BARRINGTON, Illinois (January 25, 2022) — A pair of new studies help establish the relative prevalence of signs and symptoms of the eyes of rosacea patients (ocular rosacea), as well as the importance of medical therapy.

BARRINGTON, Illinois (Nov. 9, 2021) — The National Rosacea Society (NRS) has awarded funding for two new studies in addition to continuing support for two ongoing studies as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.

BARRINGTON, Illinois (August 23, 2021) — New recommendations urging dermatologists to place greater emphasis on persistent facial erythema in rosacea were recently published in the Journal of Drugs in Dermatology.¹ Titled “Update on Facial Erythema in Rosacea,” the new publication is based on a recent National Rosacea Society (NRS) roundtable to discuss this key aspect of the disorder in light of its recently updated standard classification system and standard management options, new burden-of-illness study results, and significant advances in medical th